17 Oct Autologous Stem Cell Transplantation for Amyloidosis Patient
Light chain amyloidosis results from clonal plasma cells; however, cell therapy directed against these clone cells has remained the most effective treatment for the condition. Over time, autologous stem cell transplantation (ASCT) has become a critical treatment resource for addressing light-chain amyloidosis.
Following ASCT, patients with a standard white blood cell and platelet count have shown a longer overall survival rate. But what exactly is amyloidosis, and why is autologous stem cell transplantation an effective treatment?
WHAT IS AMYLOIDOSIS?

SYMPTOMS OF AMYLOIDOSIS
It takes a considerable amount of time before amyloidosis symptoms begin to show. These symptoms also vary, depending on the affected organs. However, some known symptoms include the following;
- Shortness of breath
- Ankles and legs swelling
- Diarrhea and constipation, possibly with blood.
- Acute weakness and fatigue
- Skin changes, including thick bruising and purple patches around the eye
- An enlarged tongue with wrinkled edges
Amyloidosis is very rare, and some of its risk factors include age, sex, race, kidney dialysis, family history, and other severe medical conditions. If any of the symptoms associated with this condition is experienced, a medical professional should be seen immediately.
AUTOLOGOUS STEM CELL TRANSPLANT
Pairing high-dose chemotherapy with an autologous stem cell transplant has been found to be effective in triggering complete remissions in a high number of patients. This has led to ASCT being adopted for the systemic treatment of AL amyloidosis.
In truth, autologous stem cell transplant is associated with a consistently high hematologic response rate – a normal count of white blood cells and platelets. This evidently leads to improved organ function, survival, and a better quality of life. Based on previous tests, this therapy yields better results from previous tests in patients with one to two organ functions and no cardiac defect. However, this therapy is unsuitable for patients with over two organ involvement and cardiac involvement.
This highlights the importance of patient selection in ASCT to ensure safety and optimal outcome. Autologous stem cell transplant should only be administered to patients who are healthy enough to endure it. While ASCT remains an effective treatment for AL amyloidosis, its evolution remains probable in order to generate more effective therapy.
R3 Stem Cell offers autologous stem cell transplant therapy in Phoenix, AZ. Our centers have professionals who can carry out diagnostics for accurate patient selection and deliver stem cell therapy to treat and reduce the symptoms of amyloidosis. Contact us today.
Brand Ambassador Gallery
The USA stem cell leader offers procedures in
7 Countries including:
SUCCESS STORIES






R3 STEM CELL MASTER CLASS
Learn everything you need to know about the ever expanding field of regenerative medicine in this 8 part series that includes over four hours of entertaining content!

R3 STEM CELL INTERNATIONAL
R3 Stem Cell International includes 45 clinics in 7 countries. These Centers of Excellence treat all types of conditions with safe, effective protocols by expert stem cell physicians.

FREE STEM CELL CONSULTATION
R3 Stem Cell offers a no cost consultation to see if you or a loved one is a candidate for regenerative cell therapies including cytokines, growth factors, exosomes, and stem cells.

PROVIDER PARTNERSHIP
The R3 Partnership Program offers providers an all-in-one regenerative practice program including marketing, consultations and booked procedures!
ABOUT US
The information provided by R3 Stem Cell is not a substitute for professional medical advice, diagnosis, or treatment. Individual results may vary and only your medical professional can explain all the risks and potential benefits of any therapy based on your circumstances. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.






CALIFORNIA
- San Jose
- Fresno
- Anaheim
- Bakersfield
- Chula Vista
- Corona
- Elk Grove
- Escondido
- Fremont
- Fontana
- Fullerton
- Hayward
- Huntington Beach
- Garden Grove
- Irvine
- Sacramento
- Lancaster
- Long Beach
- Los Angeles
- Modesto
- Moreno Valley
- Oakland
- Oceanside
- Ontario
- Orange
- Oxnard
- Palmdale
- Pomona
- Rancho Cucamonga
- Riverside
- Roseville
- Salinas
- San Bernardino
- Santa Ana
- Santa Clarita
- Santa Rosa
- Stockton
- Sunnyvale
- Torrance
FLORIDA
- Jacksonville
- Cape Coral
- Fort Lauderdale
- Hialeah
- Hollywood
- Miami
- Miramar
- Orlando
- Pembroke Pines
- Port St. Lucie
- St. Petersburg
- Tallahassee
- Tampa
GEORGIA
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
NEBRASKA
NEW JERSEY
NEW YORK
NEW MEXICO
NEVADA
NORTH CAROLINA
OHIO
OKLAHOMA
OREGON
PENNSYLVANIA
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
The USA stem cell leader offers procedures in
7 Countries including:
Copyright © 2017-2023 R3 Stem Cell. All Rights Reserved.
Sorry, the comment form is closed at this time.